The percentage of T lymphocytes with co-expression of TIGIT+ and CD4+ is higher in CLL patients with a worse prognosis, determined by advanced disease stage, unmutated IGHV genes, or unfavorable cytogenetics. Here, TIGIT is linked to B-cell chronic lymphocytic leukemia.